This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 112/14/2149    most recent CIRCULATIONAHA.105.566190v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tang, X.-L. Articles by Bolli, R. Search for Related Content PubMed PubMed Citation Articles by Tang, X.-L. Articles by Bolli, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cholesterol Related Collections Animal models of human disease Ischemic biology - basic studies

(Circulation. 2005;112:2149-2156.)
© 2005 American Heart Association, Inc.

Heart Failure

Hypercholesterolemia Abrogates Late Preconditioning via a Tetrahydrobiopterin-Dependent Mechanism in Conscious Rabbits

Xian-Liang Tang, MD; Hitoshi Takano, MD; Yu-Ting Xuan, PhD; Hiroshi Sato, MD; Eitaro Kodani, MD; Buddhadeb Dawn, MD; Yanqing Zhu, MD; Gregg Shirk, BA; Wen-Jian Wu, BS; Roberto Bolli, MD

From the Institute of Molecular Cardiology, University of Louisville and the Jewish Hospital Heart and Lung Institute, Louisville, Ky.

Correspondence to Roberto Bolli, MD, Division of Cardiology, University of Louisville, Louisville, KY 40292. E-mail rbolli{at}louisville.edu

Received June 1, 2005; accepted July 5, 2005.

Background— Although the late phase of ischemic preconditioning (PC) is known to confer cardioprotection in healthy animal models, it is unknown whether this phenomenon exists in the presence of hypercholesterolemia. The goal of this study was to determine whether the infarct-sparing effect of late PC is affected by hypercholesterolemia and, if so, whether a tetrahydrobiopterin (BH₄)-dependent mechanism is responsible for the loss of late PC.

Methods and Results— Conscious rabbits fed a normal diet or a 1% cholesterol diet for 6 weeks were subjected to ischemic PC (six 4-minute coronary occlusion/4-minute reperfusion cycles) and, 24 hours later, underwent a 30-minute occlusion followed by 3 days of reperfusion. A total of 125 rabbits were used. In normocholesterolemic rabbits, ischemic PC reduced infarct size, an effect that was abrogated by administration of the BH₄ synthesis inhibitor N-acetylserotonin (15 mg/kg IV) before the 30-minute occlusion. In hypercholesterolemic rabbits, however, ischemic PC failed to reduce infarct size. Myocardial BH₄ levels in the ischemic zone increased 24 hours after ischemic PC in normocholesterolemic rabbits but not in hypercholesterolemic rabbits. In addition, in normocholesterolemic rabbits, pretreatment with N-acetylserotonin completely abolished the ischemic PC-induced increase in myocardial BH₄ levels.

Conclusions— This study demonstrates that (1) hypercholesterolemia abrogates both the infarct-sparing effect of late PC and the concomitant upregulation of myocardial BH₄, and (2) inhibition of myocardial BH₄ synthesis in the absence of hypercholesterolemia is sufficient to abolish the infarct-sparing effect of late PC. The results support the concept that hypercholesterolemia abrogates late PC by preventing the upregulation of BH₄, an essential cofactor for inducible nitric oxide synthase.

Key Words: infarction • ischemia • hypercholesterolemia • reperfusion • nitric oxide synthase